NCT06351696CompletedPhase 2/3
The Effects of Bromelain Supplement in Patients With Ulcerative Colitis
The Effects of Low FODMAP Diets Accompanied With and Without Bromelain Supplement on Quality of Life, Disease Activity Index and Inflammation in Patients With Ulcerative Colitis With and Without Primary Sclerosis Cholangitis
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
In this study, patients with active mild to moderate UC with or without PSC will be randomized to receive either bromlein or placebo along with low FODMAP diet for 8 weeks. IBDQ, SCCAIQ, CRP, TAC, TNF-a will be measured before and after the intervention.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2/3
- Study type
- Interventional
- Enrollment
- 52 (actual)
- First submitted
- 2 Apr 2024
- Start date
- 20 Apr 2024
- Primary completion date
- 10 May 2025
- Lead sponsor
- National Nutrition and Food Technology Institute
- Diseases
- Ulcerative colitis
- NCT number
- NCT06351696
What you commit to
- Study type: Interventional · Phase 2/3
- Participants enrolled: 52
- From 20 Apr 2024 to the primary completion date, 10 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- changed the type and dosage of their medication in the last month
- those who have relapses that required hospitalization and change the type and dosage of medications during the intervention
Other
- patients who do not want to continue the study protocol
Who the study is looking for
- active mild to moderate UC
- no other chronic disorders
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Azita Hekmatdoost Coordinator of this site? Confirm its status | Tehran | Iran | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.